Wikidata

(Q46007478)

English

Comment and reply on: A comparison of the estimated costs of erlotinib, docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective.

scientific article

In more languages

Statements

title
Comment and reply on: A comparison of the estimated costs of erlotinib, docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19450092
retrieved
18 December 2017
reference URL
http://europepmc.org/abstract/MED/19450092

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46007478&oldid=1577705275"